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Abstract  
 
Background: In Burkina Faso, leaves of Cassia alata are used in the treatment of several diseases, including 
inflammation. This study evaluated the anti-inflammatory effects of the dichloromethane extract of Cassia alata leaves 
(CF-AECal) on different models of inflammation in wistar rats in order to enhance its use in traditional medicine.  
Materials and Methods: Acute inflammation was induced among rats with 0.1 ml of carrageenan, serotonin, 
histamine and dextrane 1%. The effects of the CF-AECal 50 mg/kg and 100 mg/kg were compared to the effects of 
diclofenal 5 mg/kg, prednisone 5 mg/kg, promethazine 1 mg/kg, cyproheptadin 2 mg/kg. Cotton pellet and air pouch - 
induced granuloma permitted to study CF-AECal effects on the subacute inflammation. The ways of administrations 
were intra peritoneal for the substances of inductions and oral for the molecules of references and CF-AECal.  
Result: Carrageenan-induced paw edema has been inhibited to 52.39% by CF-AECal 50 mg/kg and 50.17% by CF-
AECal 100 mg/kg. Wet granulomas formation has been inhibited by CF-AECal 50 and 100 mg/kg to 20.94 and 
57.82%. The dry granulomas were inhibited at 24.32 and 59.04% by CF-AECal 50 and 100 mg/kg. Air pouch fluid was 
significantly reduced by CF-AECal in comparison to the control group. There was a massive recruitment of leukocytes 
in the pocket granuloma of the control group. CF-AECal caused strong inhibition of this infiltration of leukocytes (p< 
0.001).  
Conclusion: Dichloromethane extract of Cassia alata showed anti-inflammatory effects. 
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Introduction 
 
Inflammation is a local response of living tissue of mammals to consecutive various attacks that can be 
physical, chemical, biological (immune response) or infectious. Several mediators such as histamine, serotonin, 
bradykinins and prostaglandins are involved in different phases of inflammation. Inflammation starts by a local 
vasodilation and an increase of capillary permeability causing an inflammatory edema consecutive to the passage of an 
exudate. Then the leukocytes infiltrate the inflamed tissue and finally there is formation of the granuloma 
tissue. Inflammatory diseases constitute a health problem in the world. Indeed, the non-steroidal anti-inflammatory 
drugs prescribed although efficient, generate side effects such as gastric intolerance and renal failure that impede their 
use to the long short (Gaziano et al., 2006; Corrado et al., 2009). These side effects are related to inhibition of 
cyclooxygenase constitutive and inducible by the conventional NSAIDS. The NSAIDS with selective action on 
cyclooxygenase inducible reduce gastro intestinal ulcers but increase the cardiovascular risk (Zeilhofer, 2007). For 
bearing to these secondary effects, patients use medicinal plants with anti-inflammatory activity. Among them, 
Cassia alata or Senna alata (Caesalpiniaceae) is used in the tropical countries. Previous studies showed that Cassia 
Article History 
Received: Nov. 2, 2017 
Revised Received: Nov. 29, 2017 
Accepted: Nov. 29, 2017 
Published Online: Dec. 29, 2017 
175 
 
alata possesses broncho-relaxing and anti-genotoxic activities (Ouedraogo et al., 2013), laxative, anti-inflammatory, 
anti-mutagenic, analgesic and antimicrobial properties (Khan et al., 2001; Somchit et al., 2003; Villasenor et al., 2002).  
Other studies showed that Cassia alata inhibits the installation of diabetes (Villasenor et al., 2002). In Burkina 
Faso, the leaves of Cassia alata are used in the treatment of several diseases; including inflammation 
(Nacoulma/Ouedraogo, 1996). The aim of this study was to evaluate the anti-inflammatory activity of dichloromethane 
fraction of Cassia alata, on acute and subacute animal models. 
 
Materials and Methods 
Preparation of the plant 
 
Leaves of Cassia alata were harvested in Ouagadougou at September 2013 and identified by Dr Ouedraogo of 
University Ouaga1 Pr Joseph KI-ZERBO, where a voucher specimen n°15965 was deposited. The leaves were dried at 
room temperature and crushed into powder. One kilogram of powder of Cassia alata was macerated at room 
temperature in alcohol 80% for 48 hours. Preparation was filtered using a whatman paper, concentrated in a rotary 
evaporator under reduced pressure and lyophilized. The yield was 13.75 %. This extract (10g) was dissolved in distilled 
water (75 ml). The aqueous extract obtained was introduced into a separating funnel and 75 ml of hexane was added. 
The mixture was shaken vigorously. The agitation was marked by periods of lower pressure in the bulb. After thirty 
minutes of decantation, hexane fraction which was distinguished clearly from aqueous fraction was collected. The same 
procedure was repeated three times with the aqueous fraction that remained. All fractions in the hexane were 
concentrated in the rotavapor. Dichloromethane (75 ml) was added to the aqueous fraction. The same procedure 
described above was followed to obtain the final fraction of dichloromethane (CF-AECal). 
 
Qualitative phytochemical analysis of Cassia alata  
 
Preliminary chemical tests have been done with the dichloromethane extract to identify different phyto-
constituents (Odebiyi et Sofowora, 1978) 
 
Drugs and reagents 
 
Carrageenan, serotonin, histamine, dextran were purchased from Sigma Aldrich Chemicals, Bangalore; 
diclofenal (Gift sample from Glenmark Laboratories Ltd. Mumbai), prednisone, promethazin, cyproheptadin were used 
for the various tests. All drugs were dissolved in sterile saline (NaCl 0.9%). 
 
Animals 
 
Albino swiss rats of Wistar stump from the pet center of the Faculty of Science, University Yaoundé I; was 
used. The rats were from 7 to 9 weeks-olds and weighing 120 g to 150 g. The animals received water and food ad 
libitum, at room temperature conditions (25 ± 2°C) and 12:12 h light/dark cycle. They were divided into groups of five 
rats each. Twelve hours before the experiment, animals were fasted. The rats were anaesthetized with intraperitoneal 
injection of diethyl ether. All animal handling and procedures strictly conformed to the Guide for the Care and Use of 
Laboratory Animals (National Institutes of Health, Publication no. 85-25, revised 1996). 
 
Acute inflammation  
Carrageenan induced rat paw edema 
 
Four groups of rats were used for experimentation. For each rat, initial volume (Vo) of the right hind paw was 
measured with the plethysmometer 37140 Ugo Basile. The rats of group 1 received distilled water orally (negative 
control). Animals of groups 2 and 3 received 50 and 100 mg/kg of dichloromethane extract of Cassia alata respectively 
by oral route. Rats of group 4 received diclofenal (5 mg/kg) by oral gavage (positive control). Thirty minutes after this 
treatment, each rat received subcutaneous injection of carrageenan 1 % (0.1 ml) under plantar fascia on the right hind 
paw. Paw oedema evolution was determined 30 min, 1 h, 2 h, 3 h, 4 h, 5 h and 6 h after induction of inflammation 
(Dongmo et al., 2003; Winter, 1962). 
 Oedema size was appreciated by the determination of increase of rat paw volume. Percentage of inhibition (Pi) was 
obtained by the following formula: 
 
 
 
 
Where Pi is the percentage of inhibition of oedema, V0 and Vt are the average initial paw volume of rats and the 
average volume of paw at a time “t” after induction of inflammation, respectively.  
 
Serotonin and histamine induced edema 
Rats received distilled water (p.o.), dichloromethane extract of Cassia alata (50 or 100 mg/kg, p.o.). 
Prednisone (5 mg/kg, p.o.) and promethazine (1 mg/kg) were used as reference drugs for serotonin and histamine 
Pi (%) = 
(Vt - V0) control - (Vt -V0) test 
(Vt - V0) control 
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induced paw oedema, respectively. Thirty minutes after the treatment of animals, they received subplantar injection of 
serotonin 1% (0.1 ml) or histamine 1% (0.1 ml). Oedema was determined 30 or 60 min after serotonin (Lanher et al., 
1991; Dimo et al., 2006) or histamine injection (Dimo et al., 2006; Singh et al., 1996), respectively. Percentage of 
inhibition (Pi) is obtained by the previous formula.  
 
Dextran-induced paw edema 
 
Rats were treated with distilled water, CF-AECal (50 mg/kg or 100 mg/kg) or cyproheptadin (2 mg/kg) one 
hour before subplantar injection of dextran solution (1%, 0.1 ml) on the paw rear right (Mandal et al., 2000). Paw 
edema of each animal was measured before dextran injection (Vo) and 30 min, 1 and 2 hours after induction of 
inflammation. Percentage of inhibition was calculated as previously described. 
 
Subacute inflammation 
Cotton pellet granuloma model 
 
Twenty five rats were anesthetized by intraperitoneal injection of valium (2 ml/kg) and ketamine (10 ml/kg). 
Two cotton balls weighing 7 mg each were sterilized during 24 hours at 40 ± 0.5 °C. Sterilized cotton pellets were 
implanted subcutaneously in the inguinal region of each rat, under sterile conditions. The rats of normal group received 
only distilled water. The other groups of rats were daily treated with distilled water, diclofenal (5 mg/kg), CF-AECal 
(50 or 100 mg/kg) for seven days. The eighth day of the experiment, the animals were anesthetized and sacrificed by 
decapitation. Blood was collected in EDTA tubes and used for haematological parameters. Wet granulomas were 
removed and weighted. They were dried at 60 ± 0.5°C for 24 hours for determination of dried granulomas (Ismail et al., 
1997; Subhadradeci et al., 2010). The percentages of inhibition (Pi) of wet and dry granulomas are obtained by the 
formula: 
 
 
 
 
 
 
Carrageenan-induced inflammation in the air pouch 
 
Twenty five rats were used for the experimentation. They were anesthetized by injection of valium (2 ml/kg) 
and ketamine (10 ml/kg) intraperitoneally. Pouch was formed by injection of 6 ml of air subcutaneously in the back of 
the animal. It was immediately filled by injection of carrageenan 2% (4 ml). Animals received a daily treatment with 
distilled water, diclofenal (5mg/kg), CF-AECal (50 and 100 mg/kg) and by oral route for six days. Normal group 
received only distilled water. On the 7
th 
day of the experiment, rats were anesthetized with ether and then sacrificed by 
decapitation. Pouch fluid was collected by puncture and quantified. Exudate was diluted in NaCl 0.9% and the number 
of leukocytes was counted under light microscope (Selye, 1957). The number of cells per mm³ was calculated by the 
formula: 
 
X =
N x fd x 106
n x V
 
X = number of leukocytes per liter of blood; N = number of cells counted in the grid; fd = factor of dilution; n = 
number of grids counted; V = volume of a grid (0.01 mm³). 
Pouch granuloma was removed and weighted in wet state and dry state after 24 hours in the oven at 60 ± 0.5°C. Wet 
and dry granulomas inhibition (Pi) was obtained by the previous formula. 
 
Statistical analysis 
 
The experimental results were expressed as the mean ± SEM for six animals in each group. The biochemical 
parameters were analyzed statistically using one-way ANOVA followed by Newman-keuls post hoc test with the help 
of Graph Pad Prism 5.03 software. P value of < 0.05 was considered as statistically significant. 
 
 
 
 
 
 
 
 
 
Percentage inhibition   = 
Control - Treated 
Control 
X  100 
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Results 
 
The results of qualitative phytochemical analysis of the dichloromethane extract of Cassia alata leaves is 
shown in Table 1 
Table 1: Preliminary qualitative phytochemical analysis of Cassia alata leaves 
 
 
 
 
 
 
 
 
 
 
 
 (-): No presence, (+): presence 
 
 
Acute anti-inflammatory studies  
Carrageenan induced rat paw edema 
 
The results of the anti-inflammatory effects of CF-AECal on carrageenan-induced edema are summarized in 
Table 2. CF-AECal 50 and 100 mg/kg and diclofenal exhibited a maximum effect 5 hours after injection of 
carrageenan, reducing inflammation by 52.39 %, 50.17 % and 75.14 % respectively. 
 
Table 2: Effect of CF-AECal on carrageenan induced-paw volume in rats 
 
The values are expressed as mean ± SEM, (n = 5). The values in parentheses represent the percentages of inhibition. ** 
p< 0.01, *** p<0.001 compared to control animals. CF-AECal = dichloromethane fraction of Cassia alata aqueous 
extract. 
 
Dextran-induced paw edema 
 
Dextran-induced paw oedema was reduced all over the experiment by CF-AECal, which exhibited a maximum 
effect of 53.27% at the dose of 100 mg/kg one hour after induction of inflammation. (Figure1). 
Dichloromethane extract of  
Cassia alata leaves 
Results 
Alkaloids + 
Phenols + 
Flavonoids + 
Tannins + 
Anthraquinons + 
Saponins + 
Triterpenes - 
Treatments Doses 
(mg/kg) 
Paw volume (ml) 
0,5 h 1 h 2 h 3 h 4 h 5 h 6 h 
       
Control  0.81 ± 
0.02 
0.87 ± 
0.01 
1.68 ± 
0.03 
1.82 ± 
0.07 
2.05 ± 
0.04 
1.71 ± 
0.04 
1.76 ±  
0.05 
CF-AECal 50 0.67 ± 
0.02** 
(17.69) 
0.79 ±  
0.01 
(10.04) 
1.09 ±  
0.04*** 
(35.47) 
1.39 ±  
0.06*** 
(23.49) 
1.36 ±  
0.07*** 
(33.85) 
0.82 ±  
0.06*** 
(52.39) 
0.85 ±  
0.05*** 
(51.53) 
CF-AECal 100  0.8 ±  
0.04 
(1.72) 
0.46 ±   
0.04 *** 
(47.26) 
0.91 ±  
0.03*** 
(46.26) 
1.23 ± 
 0.08*** 
(32.27) 
1.53 ±  
0.06 *** 
(25.56) 
0.85 ±  
0.02*** 
(50.17) 
0.9 ±  
0.03*** 
(49.03) 
Diclofenal  5 0.62 ± 
0.01*** 
(23.83) 
0.47 ± 
0.05*** 
(46.35) 
0.83 ± 
0.05*** 
(51.01) 
1.15 ±  
0.07*** 
(36.66) 
1.33 ±  
0.05*** 
(35.12) 
0.43 ± 
 0.05*** 
(75.14) 
1.33 ± 
 0.07*** 
(24.40) 
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Serotonin and histamine induced oedema 
 
Serotonin and histamine-induced paw oedema were reduced by the extract of Cassia alata. Thirty minutes 
after Serotonin administration, paw oedema was inhibited by 22.22%, 51.06% and 68.79% by CF-AECal (50 and 100 
mg/kg) and cortancyl, respectively. When administered at 100 mg/kg, the anti-inflammatory effect of the plant extract 
(29.45%) against histamine-induced paw oedema was comparable to the effect of promethazine (31.29%) (Table 3).  
 
Table 3: Effects of CF-AECal, on acute inflammation induced by serotonin and histamine in Wistar rats  
Treatments Doses (mg/kg) Paw volume (mL) 
Serotonin                                          Histamine 
Control  0.846 ± 0.017 3.26 ± 0.163 
CF-AECal 50 0.658±0.022*** (22.22) 2.44 ± 0.067*** (25.15) 
CF-AECal 100 0.414 ± 0.027*** (51.06) 2.3 ± 0.118***   (29.45) 
Cortancyl  5 0.264 ± 0.036***  (68.79) - 
Promethazine  1 - 2.24 ± 0.050*** (31.29) 
The values are expressed as mean ± SEM, n = 5. The values in parentheses represent the percentages of inhibition. *** 
p<0.001 compared to control animals. CF-AECal = dichloromethane fraction of Cassia alata aqueous extract. 
 
Subacute anti-inflammation studies 
Cotton pellet-induced granuloma formation 
 
As shown in Table 4, CF-AECal inhibited the granuloma formation, with a maximum reduction of wet weight 
(27.61%) and the dry weight (23.65%) of cotton observed at 100 mg/kg, compared to the control group.  
 
Table 4: Effect of CF-AECal on cotton pellet- induced granuloma formation in rats  
Treatments Doses 
(mg/kg) 
Wet weight of cotton 
(mg) 
% INH Dry weight of 
cotton (mg) 
% INH 
Control  221.45 ± 7.36   42.7 ± 1.90  
CF-AECal 50 192.6 ± 6.43 * 13.03 35.8 ± 1.31 ** 16.15 
CF-AECal 100 160.3 ± 8.24 *** 27.61 32.6 ± 1.2 *** 23.65 
Diclofenal 5 162.5 ± 8.88 *** 26.62 29.6 ± 0.4 *** 30.68 
The values are expressed as mean ± SEM, (n = 5). * p<0.05, ** p< 0.01, *** p<0.001 compared to control animals. 
CF-AECal = dichloromethan fraction of Cassia alata aqueous extract. 
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Carrageenan induced inflammation in the air pouch 
 
CF-AECal 50 mg/kg inhibits wet granulomas at 20.94 % and dry granulomas at 24.32 %. CF-AECal 100 
mg/kg inhibits wet granulomas at 57.82 % and dry granulomas at 59.04 %. Pouch fluid volume and leukocytes 
infiltration are significantly reduced by CF-AECal in comparison to the control group (p< 0.001) (Figure 2). 
 
 
Carrageenan-induced granuloma was responsible for an increase of white blood cells count. The treatment of 
rats with CF-AECal (50 or 100 mg/kg) significantly decreased the number of lymphocytes and monocytes compared to 
negative control (Table 5). 
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Table 5: Effect of CF-AECal on various haematological parameters in air pouch inflammation  
The values are expressed as mean ± SEM, (n= 5) *p< 0.05, **p< 0.01, ***p< 0.001 compared to negative control 
animals. 
#
p< 0.05, 
##
p< 0.01, 
###
p< 0.001 compared to neutral control animals. CF-AECal = dichloromethan fraction of 
Cassia alata aqueous extract. 
 
Discussion 
 
Inflammation constitutes the response of body to injury and is characterized by a series of events that mainly 
occur in three distinct phases. The first phase is caused by an increase in vascular permeability resulting in exudation of 
fluids from the blood into the interstitial space; the second phase involves the infiltration of leukocytes from the blood 
into the tissue and the third phase is characterized by granuloma formation and tissue repair (Badgujar et al., 2009). 
One of the causes of inflammatory reactions in our study is the tissue injury that induces synthesis of histamine, 
prostaglandins, leukotrienes (Ammon et al., 1993), PAF (platelet activating factor), cytokines, NO (nitric oxide) and 
TNF α (tumor necrosis factor) (Clarke et al., 1996). 
Carrageenan induced rat paw oedema is a suitable in vivo model to predict the value of anti-inflammatory 
agents, which act by inhibiting the mediators of acute inflammation (Morebise et al., 2002). Development of edema in 
the paw of the rats is due to the release of histamine, serotonin and prostaglandin like substances (Umesh et al., 2011). 
Our study show that CF-AECal inhibited the carrageenan induced rat paw oedema formation during both early and 
later phases. This result suggests that the inhibitory effect of the extract on oedema formation is probably due to the 
inhibition of the synthesis or release of the inflammatory mediators, especially histamine, serotonin and 
cyclooxygenase products. To ascertain the activity of the plant extract on inflammatory mediators, its effect was 
evaluated on dextran, histamine and serotonin induced paw oedema.  
Dextran is a polysaccharide of high molecular weight that induces anaphylactic reaction, characterized by 
extravasation and oedema formation, as a consequence of liberation of histamine and serotonin from mast cells (Van 
Wauwe et al., 1989; Prakash et al., 2009).  
Histamine, one of the important inflammatory mediators, is a potent vasodilator which increases vascular 
permeability (Linardi et al., 2000; Cuman et al., 2001). CF-AECal significantly suppressed dextran, histamine and 
serotonin-induced oedema. The results correlated with those observed during the first phase of carrageenan-induced 
paw oedema.  
Subchronic and chronic models have been employed to assess the transudative and proliferative components 
of chronic inflammation. The fluid adsorbed by the pellet greatly influences the wet weight of the granulomas whereas 
the dry weight correlates well with the amount of granulomatous tissue formed. The results show inhibitions of wet and 
dry granulomas by CF-AECal. The pouch fluid volume was also significantly reduced by CF-AECal. This reduction in 
transudate and granuloma formation may correlate with the ability of the plant extract to inhibit collagen and 
mucopolysaccharides synthesis and reduce the number of fibroblasts involved in the formation of granuloma tissue 
(Mallat et al., 1995; Chandrasekaran et al., 2013). The migration of leukocytes at the site of inﬂammation is an 
important parameter in the inﬂammatory response. The migration of leukocyte occurs as a result of different processes 
including adhesion and cell mobility (Meade et al., 1986). CF-AECal inhibited leukocyte accumulation in 
inflammatory pouch fluid. 
Anemia is commonly noted in patients with subchronic inflammation. The two most common explanations are 
gastrointestinal blood loss due to anti-inflammatory drugs and bone marrow changes in patients with inflammatory 
arthritis, which prevents the release of iron for incorporation into red blood cells (Mowat, 1971; Allar et al., 1977). In 
our study, control rats showed a reduced RBC count. Animals treated with CF-AECal showed a significant recovery 
from the induced anemia. An indicator of infectious and inflammatory diseases, the WBC count increased in control 
rats (Maria et al., 1983). The migration of leukocytes to the inflamed area was significantly suppressed by CF-AECal. 
 
 
 
Heamatological 
parameters 
Treatments and doses (mg/kg) 
Neutral 
control 
Negative 
Control 
CF-AECal  
(50 mg/kg) 
CF-AECal  
(100 mg/kg) 
Diclofenal  
(5 mg/kg) 
           
WBC x 10 
3 
/ µL 10.13 ±2.71 ### 22.80 ±2.1 *** 19.5 ±2.40 # 18.93 ±4.06 # 14.03±0.66 ## 
Lymphocyt x 10 
3 
/µL 6.52  ± 1.71 ## 13.57 ±2.24 ** 11.73 ±1.44 # 10.27 ±2.71 # 10.89 ±0.50 # 
Granulocyt x 10 
3 
/ µL 1.39 ± 0.47 ### 4,25 ±  0,29 
*** 
4.00 ± 0,65 ** 4.97 ± 0,76 *** # 0.95 ±0.07 
### 
Monocyt  x 10 
3 
/ µL 2.23 ± 0,67 ### 4.99 ±0.34 *** 3.78 ±0,31 ## 3.67 ±0,71 ## 2.20 ±0.12 
### 
RBC x 10 
6 
/µL 6.66 ±0.01 ### 5.04 ±0,26 *** 5.16 ±0,07 *** 5.36 ±0,02 *** 
  
5.63 ±0.38 * 
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Conclusions 
 
The findings of the present study have demonstrated that CF-AECal has potent anti-inflammatory activity and 
justify its use in traditional medicine to treat inflammatory. The results also show evidence that the beneficial effects of 
this plant may be due to its free radical scavenging activities. 
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